Brisbane Clinical Trials
The Brain Study
The study drug is a potential new treatment for acute ischemic stroke (AIS).
11 nights
1 visits
The study drug is administered via intravenous (IV) infusion.
Stroke is the second leading cause of death globally, with nearly 5.5 million deaths every year. Current treatments have their limitations, mainly because they should be administered within a short time after the occurrence of the stroke.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Eligibility
Biological Sex Healthy males and females of Caucasian descent with 2 biological Caucasian parents and 4 biological Caucasian grandparents
Age 18-55 years old
BMI 18-32 kg/m
Weight ≥50 kg (male participants) or ≥45 kg (female participants
Medical History No significant medical history
Medications Not taking any medication
Smoking History Non-smokers and casual smokers only (no more than 5 cigarettes/day)